Indiana University Research and Technology Corporation
发明人:
Sophie Peczesny
申请号：
US15546979
公开号：
US20180017561A1
申请日:
2016.01.28
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Th17-prone CD146+CCR5+ T-cell population as an early biomarker of intestinal graft-versus-host disease and its use for determining prognosis of intestinal GVHD before the clinical signs are apparent are disclosed.
